Roy, Pushpita, Dipaloke Banik, Forhad Chowdhury, and Md Abu Bakar Siddique. 2026. “Magnitude of Survival Benefit Associated With Tyrosine Kinase Inhibitors in Advanced Thyroid Carcinoma: A Systematic Review and Meta-Analysis Incorporating Updated Long-Term Evidence From SELECT (Lenvatinib) and COSMIC-311 (Cabozantinib) Trials”. World Journal of Oncology 17 (5): 599-613. https://doi.org/10.14740/wjon2842.